Scinovex
article Open AccessTop 10% cited

Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis

Journal of Investigative Dermatology · 2009 · Vol. 129(9) · pp. 2175–2183
Erin G. HarperChangsheng GuoHeather L. RizzoJoseph V. LillisStephen E. KurtzIliyana SkorchevaDavid E. PurdyErin FitchMihail S. IordanovAndrew Blauvelt
Psoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAsthma and respiratory diseasesCCL20PsoriasisC-C chemokine receptor type 6ChemokineTumor necrosis factor alphaImmunologyKeratinocyteCCL17Interleukin 17Cytokine

MeSH terms

Interleukin-22AnimalsCells, CulturedEpidermisHumansInterleukinsMice, Inbred BALB CPsoriasisTumor Necrosis Factor-alphaKeratinocytesInterleukin-17MiceReceptors, CCR6Chemokine CCL20

Funding

  • U.S. Department of Veterans Affairs
  • National Institutes of Health
Citations
499
FWCI
9.89
field-weighted impact
References
43
Percentile
99%
vs. same field & year
Citations per year
Cited by
Immunology of Psoriasis
Annual Review of Immunology · 2014 · 1,570 citations
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Journal of Investigative Dermatology · 2009 · 620 citations
Psoriasis pathogenesis and the development of novel targeted immune therapies
Journal of Allergy and Clinical Immunology · 2017 · 915 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.